Literature DB >> 12957287

Genetics supersedes epigenetics in colon cancer phenotype.

Kentaro Yamashita1, Tomoko Dai, Yuichi Dai, Fumiichiro Yamamoto, Manuel Perucho.   

Abstract

A CpG island DNA methylator phenotype has been postulated to explain silencing of the hMLH1 DNA mismatch repair gene in cancer of the microsatellite mutator phenotype. To evaluate this model, we analyzed methylation in CpG islands from six mutator and suppressor genes, and thirty random genomic sites, in a panel of colorectal cancers. Tumor-specific somatic hypermethylation was a widespread age-dependent process that followed a normal Gaussian distribution. Because there was no discontinuity in methylation rate, our results challenge the methylator phenotype hypothesis and its hypothetical pathological underlying defect. We also show that the mutator phenotype dominates over the gradual accumulation of DNA hypermethylation in determining the genotypic features that govern the phenotypic peculiarities of colon cancer of the mutator pathway.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12957287     DOI: 10.1016/s1535-6108(03)00190-9

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  67 in total

1.  Sporadic versus hereditary forms of colorectal cancer with the DNA microsatellite instability phenotype: to 'lump' or 'split'?

Authors:  Jeremy R Jass
Journal:  Fam Cancer       Date:  2004       Impact factor: 2.375

Review 2.  Colorectal cancer: a model for epigenetic tumorigenesis.

Authors:  J J L Wong; N J Hawkins; R L Ward
Journal:  Gut       Date:  2006-07-13       Impact factor: 23.059

Review 3.  Applying whole-genome studies of epigenetic regulation to study human disease.

Authors:  J D Lieb; S Beck; M L Bulyk; P Farnham; N Hattori; S Henikoff; X S Liu; K Okumura; K Shiota; T Ushijima; J M Greally
Journal:  Cytogenet Genome Res       Date:  2006       Impact factor: 1.636

4.  DNA demethylation in normal colon tissue predicts predisposition to multiple cancers.

Authors:  H Kamiyama; K Suzuki; T Maeda; K Koizumi; Y Miyaki; S Okada; Y J Kawamura; J K Samuelsson; S Alonso; F Konishi; M Perucho
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

5.  Colorectal cancer "methylator phenotype": fact or artifact?

Authors:  Charles Anacleto; Andréia M Leopoldino; Benedito Rossi; Fernando A Soares; Ademar Lopes; José Cláudio C Rocha; Otávia Caballero; Anamaria A Camargo; Andrew J G Simpson; Sérgio D J Pena
Journal:  Neoplasia       Date:  2005-04       Impact factor: 5.715

6.  CIMP and colon cancer gets more complicated.

Authors:  William M Grady
Journal:  Gut       Date:  2007-11       Impact factor: 23.059

7.  The CpG island methylator phenotype in colorectal cancer.

Authors:  Wade S Samowitz
Journal:  J Mol Diagn       Date:  2007-07       Impact factor: 5.568

Review 8.  Molecular classification and correlates in colorectal cancer.

Authors:  Shuji Ogino; Ajay Goel
Journal:  J Mol Diagn       Date:  2007-12-28       Impact factor: 5.568

9.  Multiplexed profiling of candidate genes for CpG island methylation status using a flexible PCR/LDR/Universal Array assay.

Authors:  Yu-Wei Cheng; Carrie Shawber; Dan Notterman; Philip Paty; Francis Barany
Journal:  Genome Res       Date:  2005-12-20       Impact factor: 9.043

10.  Epigenetic-genetic interactions in the APC/WNT, RAS/RAF, and P53 pathways in colorectal carcinoma.

Authors:  Yutaka Suehiro; Chi Wai Wong; Lucian R Chirieac; Yutaka Kondo; Lanlan Shen; C Renee Webb; Yee Wai Chan; Annie S Y Chan; Tsun Leung Chan; Tsung-Teh Wu; Asif Rashid; Yuichiro Hamanaka; Yuji Hinoda; Rhonda L Shannon; Xuemei Wang; Jeffrey Morris; Jean-Pierre J Issa; Siu Tsan Yuen; Suet Yi Leung; Stanley R Hamilton
Journal:  Clin Cancer Res       Date:  2008-05-01       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.